Heteroaryl-fused pyrimidinyl compounds as anticancer agents
Heteroaryl-fused pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
Chiron Corporation
Y A A C A C
Y10S A61P A61P C07D A61P C07D
additional inventional inventional inventional inventional inventional
Weibo Matthew T. Liana Marie Ryan N.
Wang Burger Lagniton Constantine